Select Publications
Books
, 2011, Adult gliomas; a guide for patients, their families and carers, Barton MB, (ed.), The Cancer Council Australia, Sydney, Australia
, 2009, Clinical practice Guidelines for the management of adult gliomas, Barton MB; Hovey E, (ed.), The Cancer Council Australia, Sydney, Australia
Book Chapters
2019, 'Will We Still Need Radiotherapy in 20 Years?', in MRI for Radiotherapy: Planning, Delivery, and Response Assessment, pp. 191 - 201, http://dx.doi.org/10.1007/978-3-030-14442-5_12
,2015, 'Radiotherapy', in Tropical Hemato-Oncology, Springer, pp. 511 - 518
,2013, 'Counterpoint on Glioma', in Johnson F; Maehera Y; Browman G; Margenthaler J; Audisio R; Thompson J; Johnson D; Earle C; Virgo K (ed.), Patient Surveillance After Cancer Treatment, Humana Press, New York, pp. 517 - 520
,2013, 'Glioma of the central nervous system surveillance counterpoint: Australia', in Patient Surveillance After Cancer Treatment, pp. 517 - 519, http://dx.doi.org/10.1007/978-1-60327-969-7_105
,2011, 'Radiotherapy: using risk profiling to identify errors and close calls in the process of care.', in Wu A (ed.), The value of close calls in improving patient safety, Joint Commission resources, Oakbrook Terrace, Illinois, pp. 103 - 110
,2010, 'The optimal provision of cancer treatment services', in Elwood M; Sutcliffe S (ed.), Cancer Control, Oxford University Press, Oxford, UK, pp. 169 - 184
,2007, 'Cancer centres in low and middle income countries', in Sloan FA; Gelband H (ed.), Cancer control opportunities in low and middle income countries, National Academic Press, Washington DC, pp. 253 - 271
,2007, 'The cancer burden in low and middle income countries and how it is measured', in Sloan FA; Gelband H (ed.), Cancer control opportunities in low and middle income countries, National Academic Press, Washington DC, pp. 69 - 105
,1999, 'Hodgkin’s disease presenting below the diaphragm', in Hodgkin's Disease, Lippincott Williams & Wilkins, Philadelphia, pp. 727 - 740
,1997, 'The effect of treatment time on tumour control', in Current Radiation Oncology, Arnold, London, pp. 58 - 77
,1991, 'THE EFFECT OF TREATMENT TIME ON LOCAL CONTROL IN CERVIX CANCER', in Radiation Research: A Twentieth-century Perspective, Elsevier, pp. 248 - 248, http://dx.doi.org/10.1016/b978-0-12-168561-4.50867-2
,Journal articles
2024, 'Assessing a Suitable Radiotherapy Utilisation Benchmark for Older Patients With Head and Neck Cancer', Clinical Oncology, 36, pp. e381 - e387, http://dx.doi.org/10.1016/j.clon.2024.05.014
,2024, 'Estimation of the optimal radiotherapy utilization rate for childhood neuroblastoma', Radiotherapy and Oncology, 197, http://dx.doi.org/10.1016/j.radonc.2024.110343
,2024, '129: Development of an Optimal Radiotherapy Utilisation Rate for Older Patients with Head and Neck Cancer', Radiotherapy and Oncology, 194, pp. S2764 - S2765, http://dx.doi.org/10.1016/s0167-8140(24)00856-9
,2023, 'Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers: Optimal Radiotherapy Utilisation Rate for Lung, Rectal, Prostate and Cervical Cancers', Radiotherapy and Oncology, 188, http://dx.doi.org/10.1016/j.radonc.2023.109862
,2023, 'Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images', Physical and Engineering Sciences in Medicine, 46, pp. 851 - 863, http://dx.doi.org/10.1007/s13246-023-01258-z
,2023, 'Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement', The Lancet Oncology, 24, pp. 682 - 690, http://dx.doi.org/10.1016/S1470-2045(23)00183-3
,2023, 'Response from Batumalai V et al.', Asia-Pacific Journal of Clinical Oncology, 19, pp. 415, http://dx.doi.org/10.1111/ajco.13891
,2023, 'Patterns of curative treatment for non-small cell lung cancer in New South Wales, Australia', Asia-Pacific Journal of Clinical Oncology, 19, pp. e149 - e159, http://dx.doi.org/10.1111/ajco.13811
,2023, 'Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review', Journal of Geriatric Oncology, 14, http://dx.doi.org/10.1016/j.jgo.2022.10.002
,2023, 'OC-0755 Radiotherapy Utilisation and Geriatric Oncology: Lung, Rectal, Prostate and Cervical Cancer', Radiotherapy and Oncology, 182, pp. S621 - S622, http://dx.doi.org/10.1016/s0167-8140(23)08696-6
,2022, 'Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer', Clinical Oncology, 34, pp. 561 - 570, http://dx.doi.org/10.1016/j.clon.2022.05.005
,2022, 'Great expectations or waiting for Godot? Time for development of a near real-time national reporting system of radiotherapy utilisation', Journal of Medical Imaging and Radiation Oncology, 66, pp. 826 - 829, http://dx.doi.org/10.1111/1754-9485.13437
,2022, 'Regional Variations in Clinical Trial Outcomes in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, 20, pp. 879 - 886, http://dx.doi.org/10.6004/jnccn.2022.7029
,2022, 'Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer', Journal of Geriatric Oncology, 13, pp. 844 - 849, http://dx.doi.org/10.1016/j.jgo.2022.04.003
,2022, 'Repeatability and reproducibility of magnetic resonance imaging-based radiomic features in rectal cancer', Journal of Medical Imaging, 9, http://dx.doi.org/10.1117/1.JMI.9.4.044005
,2022, 'Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation', Radiotherapy and Oncology, 170, pp. 37 - 47, http://dx.doi.org/10.1016/j.radonc.2022.02.031
,2022, 'Trends in the use of short-course radiation therapy for rectal cancer in New South Wales, Australia', Journal of Medical Imaging and Radiation Oncology, 66, pp. 436 - 441, http://dx.doi.org/10.1111/1754-9485.13364
,2022, 'Australia and New Zealand's responsibilities in improving oncology services in the Asia-Pacific: A call to action', Asia-Pacific Journal of Clinical Oncology, 18, pp. 133 - 142, http://dx.doi.org/10.1111/ajco.13544
,2022, 'Prioritising access to cancer drugs', The Lancet Oncology, 23, pp. e1 - e1, http://dx.doi.org/10.1016/S1470-2045(21)00641-0
,2022, 'Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations', International Journal of Cancer, 150, pp. 91 - 99, http://dx.doi.org/10.1002/ijc.33764
,2021, 'Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales', Clinical Oncology, 33, pp. 650 - 660, http://dx.doi.org/10.1016/j.clon.2021.02.008
,2021, 'Radiotherapy service need in the Pacific Island countries', Asia-Pacific Journal of Clinical Oncology, 17, pp. e217 - e225, http://dx.doi.org/10.1111/ajco.13437
,2021, 'Artificial intelligence in medical imaging and radiation oncology: Opportunities and challenges', Journal of Medical Imaging and Radiation Oncology, 65, pp. 481 - 485, http://dx.doi.org/10.1111/1754-9485.13275
,2021, 'Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer', Physics and Imaging in Radiation Oncology, 18, pp. 26 - 33, http://dx.doi.org/10.1016/j.phro.2021.03.003
,2021, 'Patterns of care for men with prostate cancer: the 45 and Up Study', Medical Journal of Australia, 214, pp. 271 - 278, http://dx.doi.org/10.5694/mja2.50966
,2021, 'Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia', Radiotherapy and Oncology, 156, pp. 174 - 180, http://dx.doi.org/10.1016/j.radonc.2020.12.020
,2021, 'Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis', The Lancet Oncology, 22, pp. 173 - 181, http://dx.doi.org/10.1016/S1470-2045(20)30589-1
,2021, 'Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study', The Lancet Oncology, 22, pp. 182 - 189, http://dx.doi.org/10.1016/S1470-2045(20)30675-6
,2021, 'Are nccn resource-stratified guidelines for breast cancer systemic therapy achievable? a population-based study of global need and economic impact', JCO Global Oncology, 7, pp. 1074 - 1083, http://dx.doi.org/10.1200/GO.21.00028
,2021, 'Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality', Radiotherapy and Oncology, 154, pp. 299 - 305, http://dx.doi.org/10.1016/j.radonc.2020.11.010
,2021, 'The value of first-line chemotherapy and targeted therapy in the treatment of breast cancer', European Journal of Cancer Care, 30, http://dx.doi.org/10.1111/ecc.13352
,2020, 'Dr David Green 22/07/1923 to 10/07/2020', Journal of medical imaging and radiation oncology, 64, pp. 894 - 895, http://dx.doi.org/10.1111/1754-9485.13109
,2020, 'Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia', Technical Innovations and Patient Support in Radiation Oncology, 16, pp. 17 - 23, http://dx.doi.org/10.1016/j.tipsro.2020.09.003
,2020, 'Health Economic and Health Service Issues of Palliative Radiotherapy', Clinical Oncology, 32, pp. 775 - 780, http://dx.doi.org/10.1016/j.clon.2020.06.013
,2020, 'Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications', Radiotherapy and Oncology, 152, pp. 70 - 77, http://dx.doi.org/10.1016/j.radonc.2020.07.038
,2020, 'Multicenter evaluation of MRI-based radiomic features: A phantom study', Medical Physics, 47, pp. 3054 - 3063, http://dx.doi.org/10.1002/mp.14173
,2020, 'Quality management in radiation therapy: A 15 year review of incident reporting in two integrated cancer centres', Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 15 - 20, http://dx.doi.org/10.1016/j.tipsro.2020.02.001
,